Google
 
Google

World Stem Cell Summit 2010

Sunday, December 9, 2007

[StemCells] Graft v Host SC treatment fast tracked

Osiris: FDA grants fast-track status for third indication of Prochymal
December 07, 2007: 04:54 PM EST

SAN FRANCISCO, Dec. 7, 2007 (Thomson Financial delivered by Newstex) -
- Osiris Therapeutics Inc. (NASDAQ:OSIR) after Friday's closing bell
said the Food and Drug Administration has granted its stem-cell
therapy Prochymal fast-track status for treatment of acute graft
versus host disease, or GvHD.

GvHD is a T-cell mediated inflammatory process that results in high
levels
of pro-inflammatory chemical signals called cytokines, which cause
the unbalanced activation of certain immune cells that result in
tissue damage.

A Phase III pivotal study for this indication was initiated in
November and is enrolling patients, Osiris said.

The Columbia, Md.-based biotechnology company said this is the third
indication for Prochymal that has received a fast-track designation
and has advanced into Phase III trials.

The FDA established the fast-track designation to facilitate the
development and accelerate the pre-market review of treatments for
serious and life-threatening conditions, so that these products can
reach approval more rapidly.

In 2005, FDA granted Prochymal fast-track status for the treatment of
steroid refractory acute GvHD. In 2006, it was given the designation
for the treatment of Crohn's disease. These programs are also both
enrolling patients in Phase III registration trials, the company said.

The company's stock closed down 50 cents, or almost 4$, at $12.33.

Katherine Hunt
Copyright Thomson Financial News Limited 2007. All rights reserved.

The copying, republication or redistribution of Thomson Financial
News Content, including by framing or similar means, is expressly
prohibited without the prior written consent of Thomson Financial
News.

http://money.cnn.com/news/newsfeeds/articles/newstex/AFX-0013-
21526129.htm

__._,_.___
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:

Children's Neurobiological Solutions
http://www.CNSfoundation.org/

Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123

The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Recent Activity
Visit Your Group
Yahoo! News

Get it all here

Breaking news to

entertainment news

Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Connect w/Parents

on Yahoo! Groups

Get support and

share information.

.

__,_._,___
Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time